SLQT — SelectQuote, Inc.

SelectQuote (SLQT) Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $537 million, a 12% year-over-year increase.
• Senior Revenue: $262 million, up 2% with near-record EBITDA margins of 39%.
• Adjusted EBITDA: Expected range revised to $90 million - $100 million due to headwinds.
• Operating Cash Flow: Forecasted at $25 million - $35 million, representing a significant increase compared to the previous year.
• Agent Productivity: Increased by 12% compared to two years ago, despite a lower mix of tenured agents.

2. Strategic Updates and Business Highlights

• Medicare Advantage (MA) Season: Successful execution with a 4% growth in policy volume and strong agent productivity.
• SelectRx Growth: Revenue increased by 26% year-over-year, with membership growing 17% to 113,000.
• New PBM Agreement: Entered a multiyear agreement with a key pharmacy benefit manager, enhancing visibility into drug reimbursement pricing.
• Credit Facility: Secured a new $415 million credit facility, extending debt maturities to 2031, improving capital flexibility.

3. Forward Guidance and Outlook

• Fiscal 2026 Guidance: Consolidated revenue revised to $1.61 billion - $1.71 billion, reflecting a $40 million impact from a national carrier's marketing budget cuts and PBM reimbursement changes.
• Long-term Targets: Maintained targets of 20%+ EBITDA margins for the senior division and an annualized adjusted EBITDA exit rate of $40 million - $50 million for health care services.

4. Bad News, Challenges, or Points of Concern

• Guidance Reduction: Adjusted guidance due to a $20 million impact from a national carrier's marketing budget cuts and a similar impact from PBM reimbursement changes.
• Market Dynamics: Increased competition and pressure on margins in the Medicare Advantage space, with concerns about the CMS advanced rate notice being softer than expected.
• Agent Mix: A lower mix of tenured agents due to recent hiring, although productivity per agent remains strong.

5. Notable Q&A Insights

• PBM Agreement: Management indicated the new PBM contract provides stability and predictability, mitigating the $20 million headwind as a one-time issue.
• Carrier Marketing Cuts: The decision to cut marketing budgets was not unique to SelectQuote, and management expressed confidence in navigating these changes.
• SelectRx Negotiating Power: The scale of SelectRx has improved negotiating leverage with PBMs, allowing for deeper partnerships and enhanced service offerings.
• Operational Flexibility: The new credit facility allows for strategic capital deployment across various business segments, emphasizing profitability over growth.

Overall, while SelectQuote faced unexpected headwinds impacting its short-term guidance, the company demonstrated strong operational execution and maintained a positive long-term outlook, supported by strategic initiatives and improved cash flow generation.